EP Plenary session - Oral question - Anti-Microbial resistance

EMPL 1st Trilogue on the Protection of workers from the risks related to exposure to ASBESTOS at work

BECA Special Committee - Public hearing ' Unlocking the potential of artificial intelligence in cancer research and car '

Europe's beating Cancer Plan - Let's Strive For More.

Véronique TRILLET-LENOIR in the EP in Strasbourg

MEPs vote on the following topics: Appointment of the Chair of the Supervisory Board of the European Central Bank - Tinagli; Protection of workers from asbestos - Trillet-Lenoir; Economic coercion by third countries - Lange; Intelligent Road Transport Systems - Plumb; Interim report on the proposal for a mid-term revision of the Multiannual Financial Framework - Olbrycht, Marques; European Media Freedom Act - Verheyen; Genetically modified maize MON 89034 × 1507 × MIR162 × NK603× DAS-40278-9 and nine sub-combinations; Genetically modified maize MIR 162; and ensuring European transportation works for women - Łukacijewska.

Voting session, including the European Media Freedom Act

Roberta MESOLA, EP President, gives her introductory remarks ahead the plenary session in Strasbourg in memory of the former MEP Veronique TRILLET-LENOIR (Renew, FR) who died on 9 August 2023. The statement is followed by a minute of silence. This transcription is a result of an automatic process. Please check against delivery.

Resumption of session: introductory remark by Roberta MESOLA, EP President, and minute of silence in tribute to Veronique TRILLET-LENOIR (Renew, FR), MEP since 2019

The European Union is currently facing supply shortages for many common medications and antibiotics. Painkillers and drugs against fever are for exemple in short supply in pharmacies, forcing them to start their own production. MEPs debate in plenary. Extracts.

Surge of respiratory infections and the shortage of medication in Europe: extracts from the debate

The FIFA’s decision to give the 2022 World Cup to Qatar has sparked controversy among human rights organisations and football fans alike. Data cross-checked by several human rights groups with diplomatic missions in Doha indicate that thousands of foreign workers have died on construction sites or as a result of construction-related activities in the country ahead of the tournament. MEPs debate.

Situation of human rights in the context of the upcoming FIFA world cup in Qatar: MEPs debate

Parliament debates with Council and Commission EU plans for mental health policy. MEPs quiz the Commission on what specific EU actions and proposals it is planning, in order to complement and coordinate member state mental health policy activities.

Mental health: MEPs debate

Representatives from Pfizer and Curevac share their views on past and present manufacturing, distribution and equitable access of the COVID-19 vaccines and therapeutics. The debate focuses on the activities undertaken to develop vaccines for new variants, the authorisation process, and transparency of contracts. Extracts from the exchange of views with Janine Small, President of International Developed Markets, Pfizer and and Dr Franz-Werner Haas, Chief Executive Officer, Curevac.

COVID-19 - Lessons learned and recommendations for the future: extracts from the exchange of views - EP Special Committee on the COVID-19 pandemic

By extending the mandate of the European Centre for Disease Prevention and Control, the EU aims to be better prepared and able to coordinate its response to possible future health crises. This means increased cooperation between EU, national and international bodies, collection of timely and comparable EU-wide data, as well as monitoring national health systems more closely to assess their capacity to tackle outbreaks.

European Health Union: extracts from the joint debate, the vote and statement by Véronique TRILLET-LENOIR (Renew, FR), rapporteur

MEPs debate on the provisional agreements to strengthen the EU’s capacity to prevent and control communicable diseases and tackle cross-border health threats. Closing statements by Joanna KOPCIŃSKA (ECR, PL) and Véronique TRILLET-LENOIR (Renew, FR), Rapporteurs and by Stella KYRIAKIDES, European Commissioner for Health.

European Health Union: closing statements by Joanna KOPCIŃSKA (ECR, PL), Véronique TRILLET-LENOIR (Renew, FR), Rapporteurs and by Stella KYRIAKIDES, European Commissioner for Health

MEPs debate on the provisional agreements to strengthen the EU’s capacity to prevent and control communicable diseases and tackle cross-border health threats. Opening statements by the Rapporteurs Joanna KOPCIŃSKA (ECR, PL), Véronique TRILLET-LENOIR (Renew, FR), Stella KYRIAKIDES, European Commissioner for Health, José Manuel FERNANDES (EPP, PT) BUDG committee and by Kim VAN SPARRENTAK (Greens/EFA, NL), IMCO committee. This transcription is a result of an automatic process. Please check against delivery.

Joint Debate - European Health Union: opening statements by Joanna KOPCIŃSKA (ECR, PL), Véronique TRILLET-LENOIR (Renew, FR), Rapporteurs and by Stella KYRIAKIDES, European Commissioner for Health

The deal with the Council, reached in December 2021, aims to strengthen the rules to protect workers more robustly against carcinogenic and other hazardous substances by setting EU-wide exposure limits. Parliament succeeded in including reprotoxic substances in the scope of the Directive. Reprotoxic substances are harmful to reproduction and can cause impaired fertility or infertility.

Protection of workers from the risks relating to exposure to carcinogens, mutagens and reprotoxins at work: MEPs debate

Parliament debate and vote on measures and actions to fight cancer in the EU. Key recommendations by the Special Committee on Beating Cancer (BECA) include facilitating access to cross-border health care and clinical trials, managing shortages of cancer medicines more efficiently, and ensuring equal access to innovative drugs and treatments. Closing statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety and by Véronique TRILLET-LENOIR (Renew,FR), Rapporteur

Strengthening Europe in the fight against cancer: closing statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety and by Véronique TRILLET-LENOIR (Renew, FR), Rapporteur

The European Parliament debated on Tuesday and adopted on Wednesday (652 votes in favour, 15 against and 27 abstentions) measures and actions to fight cancer in the EU. Key recommendations by the Special Committee on Beating Cancer (BECA), presided by Veronique TRILLET-LENOIR (Renew, FR) include facilitating access to cross-border health care and clinical trials, managing shortages of cancer medicines more efficiently, and ensuring equal access to innovative drugs and treatments. Véronique TRILLET-LENOIR stated that the EU would be faster and better equipped to bring down the prices of cancer drugs, which are very high. Stella KYRIAKIDES, the European Commissioner for Health and Food Safety, reminded that prevention is very important so that citizens can have specific recommendations on how they can reduce their risk of cancer. In general, MEPs agreed that a better cross-border cooperation is needed in the fight against cancer:

Strengthening Europe in the fight against cancer: extracts from the debate and the votes, statement by Veronique TRILLET-LENOIR (Renew, FR), Rapporteur

Parliament debate and vote on measures and actions to fight cancer in the EU. Key recommendations by the Special Committee on Beating Cancer (BECA) include facilitating access to cross-border health care and clinical trials, managing shortages of cancer medicines more efficiently, and ensuring equal access to innovative drugs and treatments. Opening statements by Véronique TRILLET-LENOIR (Renew, FR), Rapporteur and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety. This transcript is result of an automatic process. Please check against delivery.

Strengthening Europe in the fight against cancer: opening statements by Véronique TRILLET-LENOIR (Renew, FR), Rapporteur and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

MEPs debate with the Commission and the Slovenian Presidency the 16th December European Council agenda, in particular the coordinated fight against COVID-19. First part of the debate. Second part of the debate.

Preparation of the European Council and EU's response to the global resurgence of COVID: MEPs debate (part 2/3)

The Executive Director of the European Medicines Agency (EMA), Emer Cooke debates with the members of the Environment and Public Health Committee the latest developments in the COVID-19 vaccination campaign (including reviews, authorisations for paediatric use and boosters), as well as recent developments around COVID-19 therapeutics and the general epidemiological situation

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA) - ENVI Committee: Exchange of views

MEPs hold a debate on “The EU’s Role in Combatting the COVID-19 Pandemic: How to Vaccinate the World” during the plenary session in Strasbourg. First part of the debate.

The EU's Role in combatting the Covid-19 Pandemic - How to Vaccinate the World: MEPs debate (part 1/2)

MEPs debate proposals to address medicines shortages, improve the access of patients to treatments, and increase price transparency.

A Pharmaceutical Strategy for Europe: MEPs debate

MEPs debate recent developments and next EU steps in combatting the COVID-19 pandemic as well as how to coordinate national measures more effectively and build more solidarity among member states, in light of rising COVID-19 cases across the EU.

45 results